Cypress Capital, LLC Merck & Co., Inc. Transaction History

Cypress Capital, LLC

$388 Billion
Q3 2024

A detailed history of Cypress Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cypress Capital, LLC holds 25,007 shares of MRK stock, worth $2.45 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

25,007

Holding current value

$2.45 Million

% of portfolio

0.73%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $2.78 Million - $3.23 Million	25,007 New	25,007 $2.84 Billion
Q2 2024 Aug 22, 2024	BUY	$123.8 - $132.96 $5,571 - $5,983	45 Added 0.18%	24,479 $3.03 Million
Q1 2024 Oct 29, 2024	BUY	$113.24 - $131.95 $2.79 Million - $3.26 Million	24,671 New	24,671 $3.26 Million
Q4 2023 Dec 02, 2024	BUY	$100.18 - $109.02 $3,305 - $3,597	33 Added 10.75%	340 $37.1 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $10,418 - $11,338	104 Added 0.43%	24,434 $2.66 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $112,833 - $125,305	-1,096 Reduced 4.31%	24,330 $2.5 Million
Q2 2023 Dec 02, 2024	SELL	$108.61 - $118.38 $2.68 Million - $2.92 Million	-24,700 Reduced 98.77%	307 $35.4 Million
Q2 2023 Aug 07, 2023	BUY	$108.61 - $118.38 $23,459 - $25,570	216 Added 0.86%	25,426 $2.93 Million
Q1 2023 Dec 10, 2024	SELL	$102.94 - $114.86 $2.55 Million - $2.85 Million	-24,782 Reduced 99.1%	225 $23.9 Million
Q1 2023 Apr 27, 2023	BUY	$102.94 - $114.86 $14,102 - $15,735	137 Added 0.55%	25,210 $2.68 Million
Q4 2022 Feb 01, 2023	BUY	$87.44 - $112.11 $3,585 - $4,596	41 Added 0.16%	25,073 $2.78 Million
Q3 2022 Feb 01, 2023	BUY	$84.53 - $94.96 $61,284 - $68,846	725 Added 2.98%	25,032 $2.16 Million
Q2 2022 Aug 04, 2022	BUY	$83.49 - $94.64 $35,399 - $40,127	424 Added 1.78%	24,307 $2.22 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $51,236 - $57,432	697 Added 3.01%	23,883 $1.96 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $38,380 - $48,076	531 Added 2.34%	23,186 $1.78 Million
Q3 2021 Feb 10, 2022	BUY	$71.68 - $78.83 $317,829 - $349,532	4,434 Added 24.33%	22,655 $1.7 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $223,796 - $247,541	3,183 Added 21.17%	18,221 $1.42 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $101,017 - $118,988	1,467 Added 10.81%	15,038 $1.16 Million
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $933 - $1,035	-13 Reduced 0.1%	13,571 $1.11 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $75,082 - $85,106	-1,026 Reduced 7.02%	13,584 $1.09 Million
Q2 2020 Aug 20, 2020	BUY	$70.42 - $80.13 $265,060 - $301,609	3,764 Added 34.7%	14,610 $1.13 Million
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $30,566 - $34,490	394 Added 3.77%	10,846 $986,000
Q3 2019 Nov 21, 2019	BUY	$76.08 - $82.93 $41,007 - $44,699	539 Added 5.44%	10,452 $880,000
Q2 2019 Jul 11, 2019	BUY	$69.84 - $81.59 $692,323 - $808,801	9,913 New	9,913 $831,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital, LLC with notifications on news.

Account

Cypress Capital, LLC Merck & Co., Inc. Transaction History